Accendra Health Inc.
ACH | NYSE
$0.89
$0 (+0.03%)
Sep 21, 2026, 12:35 PM ET · Market open
Market Data
Market Cap $71.1M
Enterprise Value $1.84B
Beta 1.53
Average Volume 1.07M
Shares Outstanding (Diluted) 76.7M
Shares Change YoY -0.31%
Institutional Ownership 0.00%
Exchange NYSE
ISIN US6907321029
Price Performance
Price Change 1M -17.0%
Price Change 3M -70.9%
Price Change 6M -54.4%
Price Change YTD -59.9%
Price Change 1Y -83.2%
Price Change 3Y -94.0%
Price Change 5Y -97.0%
1M CAGR (ann.) -69.5%
1Y CAGR (ann.) -83.5%
5Y CAGR (ann.) -52.1%
All-Time CAGR -13.1%
Valuation
PE Ratio -0.24
Forward PE 8.93
PEG Ratio -0.00
Forward PEG -0.00
PS Ratio 0.03
Forward PS 0.00
PB Ratio -0.13
P/FCF Ratio -0.32
P/Adj. FCF Ratio -0.31
P/OCF Ratio -0.40
EV/Sales 0.70
EV/EBIT 220.48
EV/EBITDA 8.03
EV/FCF -8.27
Earnings Yield -420.4%
FCF Yield -313.8%
Adj. FCF Yield -320.8%
Financial Health
Net Debt $1.71B
Total Debt $1.78B
Cash & Short-Term Investments $7.65M
Total Assets $2.11B
Current Ratio 0.41
Quick Ratio 0.30
Debt / Equity Ratio -3.23
Debt / EBITDA 7.75
Debt / FCF -7.98
OCF / Debt -0.10
Interest Coverage 0.77
Altman Z-Score 0.28
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 44.8%
Operating Profit Margin 3.6%
EBITDA Margin 8.7%
Net Profit Margin -11.4%
FCF Margin -8.4%
Adj. FCF Margin -8.6%
SBC / Revenue 0.2%
SBC Impact (per share) -2.2%
Returns
Return on Assets -14.3%
Return on Equity 63.4%
Return on Invested Capital 6.4%
Return on Capital Employed 6.7%
Return on Tangible Assets -37.7%
Historical Growth (CAGR)
Revenue CAGR 3Y -36.1%
Revenue CAGR 5Y -22.3%
Revenue CAGR 10Y -12.4%
EPS CAGR 3Y -25.0%
EPS CAGR 5Y -67.6%
EPS CAGR 10Y -31.4%
FCF CAGR 3Y -198.4%
FCF CAGR 5Y -206.5%
FCF CAGR 10Y -21.8%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 15
EPS Growth Next 3Y 37.2%
Revenue Growth Next 3Y 2.6%
Earnings Date Oct 28, 2026
EPS Estimate (next Q) -$0.05
EPS Growth Est (next Q) -120.0%
Revenue Est (next Q) $619.39M
Revenue Growth Est (next Q) -11.2%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $1.50
Price Target Upside 61.3%
Cash Flow
Operating Cash Flow $-180.42M
Free Cash Flow $-223.12M
Adj. Free Cash Flow $-228.1M
FCF Per Share -$2.91
OCF Per Share -$2.35
OCF/S Ratio -6.8%
Income Statement
Revenue $2.65B
Gross Profit $1.19B
Operating Income $95.77M
EBITDA $229.78M
Net Income $-302.14M
EPS (Diluted) -$3.91
Revenue / Employee $407.27K
Profit / Employee $-46.48K
Employees 6,500
Add to Watchlist
Select watchlists to add or remove ACH